These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21742018)

  • 1. Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system.
    Burger S; Döring B; Hardt M; Beuerlein K; Gerstberger R; Geyer J
    Neuroscience; 2011 Oct; 193():109-21. PubMed ID: 21742018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system.
    Geyer J; Fernandes CF; Döring B; Burger S; Godoy JR; Rafalzik S; Hübschle T; Gerstberger R; Petzinger E
    Neuroscience; 2008 Apr; 152(4):990-1005. PubMed ID: 18355966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, sorting and transport studies for the orphan carrier SLC10A4 in neuronal and non-neuronal cell lines and in Xenopus laevis oocytes.
    Schmidt S; Moncada M; Burger S; Geyer J
    BMC Neurosci; 2015 Jun; 16():35. PubMed ID: 26084360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems.
    Arvidsson U; Riedl M; Elde R; Meister B
    J Comp Neurol; 1997 Feb; 378(4):454-67. PubMed ID: 9034903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis.
    Larhammar M; Patra K; Blunder M; Emilsson L; Peuckert C; Arvidsson E; Rönnlund D; Preobraschenski J; Birgner C; Limbach C; Widengren J; Blom H; Jahn R; Wallén-Mackenzie Å; Kullander K
    Biol Psychiatry; 2015 Mar; 77(6):526-36. PubMed ID: 25176177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
    Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains.
    Yao J; Hersh LB
    J Neurochem; 2007 Mar; 100(5):1387-96. PubMed ID: 17217417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC10A4 is a protease-activated transporter that transports bile acids.
    Abe T; Kanemitu Y; Nakasone M; Kawahata I; Yamakuni T; Nakajima A; Suzuki N; Nishikawa M; Hishinuma T; Tomioka Y
    J Biochem; 2013 Jul; 154(1):93-101. PubMed ID: 23589386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of SLC10A4, a synaptic vesicle protein in the human brain, and the association of this protein with Alzheimer's disease-related neuronal degeneration.
    Popova SN; Alafuzoff I
    J Alzheimers Dis; 2013; 37(3):603-10. PubMed ID: 23948907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dileucine motif is sufficient for internalization and synaptic vesicle targeting of vesicular acetylcholine transporter.
    Colgan L; Liu H; Huang SY; Liu YJ
    Traffic; 2007 May; 8(5):512-22. PubMed ID: 17451554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors acutely alter the sorting of the vesicular acetyl choline transporter and the vesicular monoamine transporter 2 in bimodal sympathetic neurons.
    Felder E; Dechant G
    Mol Cell Neurosci; 2007 Jan; 34(1):1-9. PubMed ID: 17059887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein.
    Bijsmans IT; Bouwmeester RA; Geyer J; Faber KN; van de Graaf SF
    Biochem J; 2012 Feb; 441(3):1007-15. PubMed ID: 22029531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synaptic protein encoded by the gene Slc10A4 suppresses epileptiform activity and regulates sensitivity to cholinergic chemoconvulsants.
    Zelano J; Mikulovic S; Patra K; Kühnemund M; Larhammar M; Emilsson L; Leão RN; Kullander K
    Exp Neurol; 2013 Jan; 239():73-81. PubMed ID: 23022458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slc10A4 - what do we know about the function of this "secret ligand carrier" protein?
    Borges K
    Exp Neurol; 2013 Oct; 248():258-61. PubMed ID: 23810836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells.
    Liu Y; Edwards RH
    J Cell Biol; 1997 Nov; 139(4):907-16. PubMed ID: 9362509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition.
    Prado VF; Martins-Silva C; de Castro BM; Lima RF; Barros DM; Amaral E; Ramsey AJ; Sotnikova TD; Ramirez MR; Kim HG; Rossato JI; Koenen J; Quan H; Cota VR; Moraes MF; Gomez MV; Guatimosim C; Wetsel WC; Kushmerick C; Pereira GS; Gainetdinov RR; Izquierdo I; Caron MG; Prado MA
    Neuron; 2006 Sep; 51(5):601-12. PubMed ID: 16950158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.